Last reviewed · How we verify

NCT06731686

Single-center Retrospective Study : Developmental Trajectories of Children Born Prematurely Before 32 Weeks Assessed With the Revised Brunet Lézine Scale at 1, 2 and 3 Years

Completed Last updated 12 December 2024
What this trial tests

trial testing Retrospective study in Premature Birth in 1,000 participants. Completed in 17 June 2024.

Timeline
23 November 2023
Primary endpoint
17 June 2024
17 June 2024

Quick facts

Lead sponsorCentre Hospitalier Intercommunal Creteil
StatusCompleted
Study typeOBSERVATIONAL
Enrollment1,000
Start date23 November 2023
Primary completion17 June 2024
Estimated completion17 June 2024
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Centre Hospitalier Intercommunal Creteil

Who can join

Adults 2 Months to 32 Months, any sex, with Premature Birth. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will assess professionals in the CHI Créteil neonatal department and the Val de Marne perinatal network to gain a better understanding of the developmental trajectories of children hospitalized at the CHI Créteil, with a view to optimizing their care in the long term

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Retrospective study

Trials testing the same drug.

Other recruiting trials for Premature Birth

Currently open trials in the same condition.

Other Centre Hospitalier Intercommunal Creteil trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06731686.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing